Dr. Mehmet Sayiner, MD

Dr. Sayiner practices at UPMC Western Maryland in Cumberland, Maryland, part of University of Pittsburgh Medical Center.

Dr. Sayiner's NPI, 1003265422, was assigned on June 7, 2016. Dr. Sayiner holds Maryland license D86926.

Dr. Sayiner's primary practice is UPMC Western Maryland, at 12500 Willowbrook Road, Cumberland, MD 21502 in Allegany County. The practice phone is (240) 964-7000.

Dr. Sayiner's primary practice is UPMC Western Maryland in Cumberland, Maryland, part of University of Pittsburgh Medical Center. Dr. Sayiner is also affiliated with Inova Fairfax Hospital. The medical group on file is US Acute Care Solutions (USACS). Dmand AI also links Dr. Sayiner to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sayiner practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sayiner's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sayiner is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sayiner's licenses on file in 2 states: Maryland and Virginia.

CMS data shows 1,185 Medicare services from Dr. Sayiner across 5 procedure codes in 2024, for 441 Medicare patients. Medicare paid $103,921 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 441 Medicare patients who saw Dr. Sayiner in 2024. The largest group is 75 to 84, with 173 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sayiner's median patient age at 64, with 50% women.

In 2024, Dr. Sayiner wrote 220 Medicare Part D claims for 101 patients. 88% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $152 in total drug cost. In 2022, CMS named 32 claims across 2 drugs.

Dr. Sayiner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 25 papers to Dr. Sayiner, published from 2015 to 2020. 2016 was the busiest year, with 6. The most frequent topics are Non-alcoholic Fatty Liver Disease, Medicare and Hepatitis C. Dr. Sayiner has published most often in Ann Hepatol. Dr. Sayiner's most frequent co-authors are Omer Shahab, MD, Svetolik Djurkovic, MD and Linda Henry, MD.